Don’t let the high cost of brand once-daily LABA/LAMA combination inhaler disrupt your COPD care. We help eligible patients access Stiolto Respimat (tiotropium/olodaterol) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
Stiolto Respimat PAP for COPD.
Eligibility verification.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$680 | Save substantially |
| CVS Pharmacy | ~$700 | Save substantially |
| Walmart | ~$520 | Save substantially |
| Costco | ~$510 | Save substantially |
Generic Anoro Ellipta | ~$80/mo | LABA/LAMA generic |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
Generic Anoro Ellipta LABA/LAMA combination dramatically cheaper.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Stiolto Respimat:
Still $500–$700 per month even with the best discount
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Stiolto Respimat assistance.
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Stiolto Respimat combines tiotropium (LAMA) + olodaterol (LABA) — once-daily dual bronchodilation for COPD. Soft mist inhaler. LABA/LAMA combinations superior to either alone for COPD with persistent dyspnea.
How Stiolto Respimat Works:
Two complementary bronchodilator mechanisms in one inhaler. LAMA blocks cholinergic constriction; LABA stimulates beta-2 relaxation. Synergistic 24-hour bronchodilation.
FLAME and other trials showed LABA/LAMA superior to LABA/ICS for many COPD patients (less pneumonia risk with LABA/LAMA). For frequent exacerbators, triple therapy (LABA/LAMA + ICS) often preferred.
Form and use:
Stiolto Respimat 2 inhalations once daily.
Generic availability:
Generic Anoro Ellipta (umeclidinium/vilanterol) now available — LABA/LAMA combination, much cheaper. Bevespi Aerosphere (glycopyrrolate/formoterol — twice daily), Duaklir Pressair (aclidinium/formoterol — twice daily). For triple: Trelegy Ellipta, Breztri Aerosphere.
Warnings:
LABA class warning for asthma-related death (Stiolto for COPD only, not asthma), cardiovascular effects, paradoxical bronchospasm, narrow-angle glaucoma, urinary retention.
Stiolto $500–$700. Generic Anoro Ellipta $80/month.
Both LABA/LAMA once-daily inhalers. Different drugs (tiotropium/olodaterol vs umeclidinium/vilanterol) — similar clinical effect. Generic Anoro dramatically cheaper.
If you have frequent exacerbations despite LABA/LAMA, triple therapy (LABA/LAMA + ICS — Trelegy, Breztri) may help. Discuss with pulmonologist.
Generic Anoro Ellipta dramatically cheaper LABA/LAMA combo. Bevespi alternative.
Generic Anoro Ellipta LABA/LAMA dramatically cheaper. Check eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.